Body Composition Analyzers Market by Product (Bioimpedance Analyzer, DEXA Scan, Skinfold Caliper, Air Displacement Plethysmography, Hydrostatic Weighing), Usage (Professional, Consumer), Modality (Portable, Stationary), End User - Global Forecast to 2031

Market Size
$0.99B
MARKET SIZE, 2026
Projected Market Size
$1.39B
MARKET SIZE, 2031
CAGR
7.1%
CAGR (2026-2031)
Forecast Period
2026-2031
FORECAST PERIOD

BODY COMPOSITION ANALYZERS MARKET SIZE, SHARE & GROWTH SNAPSHOT

body-composition-analyzers-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global body composition analyzers market is projected to grow from USD 0.99 billion in 2026 to USD 1.39 billion by 2031, at a CAGR of 7.1% during the forecast period. The market was valued at USD 0.93 billion in 2025. Factors such as increasing prevalence of obesity, increased awareness regarding preventive health care, and increasing demand from fitness and wellness centers are contributing to the market growth. Increasing use of these devices for assessing nutritional status and managing chronic ailments such as diabetes and heart disease in hospitals and clinics is contributing further to this trend. Improvements in BIA and DEXA technology, as well as the launch of cost-effective portable devices, also drive this market.

KEY TAKEAWAYS

  • MARKET SNAPSHOT:
    Base Year Market Size (2025): USD 0.93 Billion
    Current Market Size (2026): USD 0.99 Billion
    Forecast Market Size (2031): USD 1.39 Billion
    CAGR (2026–2031): 7.1%
  • SEGMENT LEADERSHIP:
    Regional Leader: Asia Pacific is anticipated to record the highest CAGR between 2026 and 2031.
    Product Leader: Bioimpedance analyzers segment accounted for a 71.0% share of the body composition analyzers market in 2025.
    Modality Leader: Portable segment is expected to register the highest CAGR of 8.2% during the forecast period.
    Usage Type Leader: Consumer-grade segment is projected to witness the highest CAGR of 9.7% from 2026 to 2031.
    Application Leader: Segmental body measurement accounted for a 57.7% share of the body composition analyzers market in 2025.
    End User Leader: Home users segment is projected to witness the highest CAGR of 8.6% during the forecast period.
  • MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
    Major players include GE HealthCare (US), OMRON Corporation (Japan), Hologic, Inc. (US), InBody Co., Ltd. (South Korea), and Tanita Corporation (Japan). These companies offer a diverse portfolio of body composition assessment technologies and compete through product innovation, advanced measurement capabilities, broad geographic presence, and applications across hospitals, clinics, fitness and wellness centers, research institutions, and home settings.
    Maltron International Ltd. (UK), Akern S.r.l. (Italy), and BioTekna (Italy), among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

With the increasing prevalence of obesity, increased interest in preventive healthcare, and the growing desire for precise and non-invasive approaches to determine fat, muscle, and water content levels, the body composition analyzers market is progressing steadily. New collaborations and developments such as partnerships between fitness tech firms and healthcare providers, investments in artificial intelligence, and innovation of portable and wearable body composition devices are changing the market landscape.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The body composition analyzers market is changing from conventional equipment and switching to connected data-driven models with the help of advancements in AI-enabled analysis, cloud-based BIA technologies, and subscription-based software solutions. This shift is taking place due to new demands of end users, with hospitals demanding better treatment monitoring, fitness clubs providing more efficient member engagement and outcomes measurement, research institutions looking for standardized and repeatable data, and home consumers wanting convenient health measurement. These factors contributed to more personalized body composition measurement processes and the accelerating usage of portable, connected, and digitally integrated body composition analyzers in the healthcare, fitness, research, and consumer fields.

body-composition-analyzers-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Rising prevalence of obesity and focus on body fat and muscle mass assessment
  • Growing adoption of body composition analysis in weight management and preventive healthcare
RESTRAINTS
Impact
Level
  • Limited reimbursement for routine body composition assessment
  • High sensitivity of bioimpedance measurements to hydration status and measurement conditions
OPPORTUNITIES
Impact
Level
  • Increasing establishment of fitness, wellness, and sports performance centers
  • Mounting demand for connected and data-driven monitoring
CHALLENGES
Impact
Level
  • Lack of standardization across BIA devices, algorithms, and measurement protocols
  • Competition from established clinical imaging technologies

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Rising prevalence of obesity and focus on body fat and muscle mass assessment

The growing prevalence of obesity and the subsequent rise in metabolic disorders are augmenting the demand for body composition analyzers. Body composition devices provide detailed insights, helping to diagnose and manage conditions such as diabetes and cardiovascular diseases. As health consciousness increases, more individuals and healthcare providers are turning to body composition analysis for effective health management. This trend is expected to significantly boost the body composition analyzers market growth.

Restraint: Limited reimbursement for routine body composition assessment

The limited possibility of reimbursement for tests of body composition is a limitation for the body composition analyzers market since many insurers do not usually make reimbursements for body composition tests when they are used for general health purposes. Also, the limited possibility of coverage and reimbursement leads to increased costs for patients and decreased interest of physicians in introducing body composition analysis into medical practice. This uncertainty in reimbursement may result in limited widespread use of high-cost professional equipment and low frequency of tests for body composition in health organizations.

Opportunity: Increasing establishment of fitness, wellness, and sports performance centers

The rising number of fitness clubs and wellness centers is creating significant growth opportunities for the body composition analyzers market. These centers are increasingly adopting advanced body composition analysis tools to offer personalized fitness and nutrition plans, which enhance their service offerings. With more people joining fitness and wellness programs, the demand for precise body composition measurement continues to rise, driving the market.

Challenge: Competition from established clinical imaging technologies

The presence of established methods of clinical imaging, especially CT and MRI, could limit the growth of the body composition analyzers market. While CT and MRI are already established in clinical practice and can provide highly detailed assessment of body composition, such as visceral and subcutaneous fat, muscle distribution, and tissue features, while simultaneously allowing the diagnosis of various diseases.

BODY COMPOSITION ANALYZERS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Manufactures Lunar iDXA, a DXA instrument with dual energy, which is often used in hospitals and research contexts to provide bone density, fat, and lean mass data; the machine produces an examination of both lean and fat masses and the total body fat percentage for body composition studies as well as understanding risk of metabolic diseases High-quality imaging and high patient weight capacity | Enables comprehensive skeletal health and body composition assessment | Detailed body composition analysis | Measures fat mass, lean mass, and body fat percentage | Metabolic health assessment | Supports evaluation of body composition-related health risks
company logo
Produces health monitoring devices available for home use and for consumer use; offers products including HBF-514C and BCM-500 blood composition monitoring devices; the OMRON BCM-500, which provides information about six body metrics and can store the results for four profiles, is one of its devices Convenient home-based monitoring | Enables regular body composition tracking outside clinical settings | Multi-parameter assessment | Provides multiple body composition metrics in a single measurement | Multi-user data tracking | Supports individual monitoring and comparison of results over time
company logo
Provides the Horizon DXA System, a dual-energy X-ray absorptiometry technology used in healthcare, clinics, and sports performance for simultaneous, accurate bone density and body composition measurements Full-body sensing | Provides more comprehensive measurements than foot-to-foot devices | Simultaneous bone & body composition assessment | Measures bone density alongside fat and lean mass | Research-based methodology | Supports repeatable and reliable results | Automated calibration & standardization | Ensures consistent measurements across large patient populations
company logo
Produces BIA-based professional devices, including the InBody 270 and InBody 970, among others, used in hospitals, clinics, and exercise centers for segmental body composition measurement; the DSM-MFBIA technology independently measures electrodes in the body's organs and limbs, therefore delivering high precision and not depending on estimation, based on gender, age, or body shape Direct segmental measurement | Provides detailed analysis of individual body segments | Multi-frequency analysis | Enables comprehensive assessment of body composition and body water | Reduced reliance on predictive equations | Supports individualized measurements without dependence on age, gender, or body shape
company logo
Manufactures multi-frequency segment analyzers, including the MC-780U Plus, that are used for in-depth body composition analysis by medical providers and fitness specialists; the device collects 31 measurements in 20 seconds, including segmental levels of fat and muscle mass, basal metabolic rate, and visceral fat Rapid comprehensive assessment | Delivers multiple body composition measurements in a short testing time | Detailed segmental analysis | Provides separate fat and muscle mass measurements for different body regions | Actionable health & fitness insights | Supports personalized assessment and program planning

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The body composition analyzers market operates within a complex interconnected ecosystem, which includes product innovation, regulatory oversight, manufacturing, distribution, and end-user adoption across multiple care settings. At the core of the ecosystem are manufacturers, including GE Healthcare (US), Omron Corporation (Japan), InBody Co., Ltd. (South Korea), Tanita Corporation (Japan), and Hologic, Inc. (US). They are supported by academic institutes, clinical research bodies, and technology partners. Surrounding this network are regulatory agencies such as the Food and Drug Administration (FDA), European Medicines Agency (EMA), and national health authorities that enforce strict compliance with device safety, sterility, performance standards, and post-market surveillance. Downstream, the ecosystem culminates with diverse end users, including fitness clubs & wellness centers, hospitals & clinics, academic research organizations, and home users whose clinical needs, workflow requirements, and safety priorities directly shape product selection, adoption rates, and long-term technology evolution within the market.

body-composition-analyzers-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

body-composition-analyzers-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Body Composition Analyzers Market, By Product

The body composition analyzers market is categorized into bioimpedance analyzers, dual-energy x-ray absorptiometry equipment, skinfold calipers, air displacement plethysmography equipment, and hydrostatic weighing equipment, based on the product. In 2025, the bioimpedance analyzers segment emerged as the leading sector in the body composition analyzers market. The large share of this segment can be attributed mainly to the use of bioimpedance analyzers in clinical settings for monitoring hydration, body composition, and diagnosing conditions such as lymphedema.

Body Composition Analyzers Market, By End User

Categorized by its various end users, the body composition analyzers market includes hospitals & clinics, fitness clubs & wellness centers, academic & research centers, and home users. As of 2025, the largest portion of the market was dominated by the fitness clubs & wellness centers segment. This dominance is largely attributed to rising consumer interest in health and fitness encouraging fitness clubs and wellness centers to invest in body composition analyzers.

REGION

Asia Pacific to be fastest-growing region in global body composition analyzers market during forecast period

The Asia Pacific body composition analyzers market is expanding due to the increasing healthcare infrastructure, rising health and fitness awareness, and investment in healthcare modernization in developing countries such as China and India. Growth is further supported by increasing disposable income, growing penetration of smart and connected health devices, and rising demand for weight management, sports performance monitoring, and clinical nutrition assessment. Additionally, the large population base, expanding middle-class population, increasing penetration of e-commerce, growing awareness of muscle health and body composition beyond BMI, and rising availability of affordable consumer-grade and locally manufactured devices are further contributing to market growth.

body-composition-analyzers-market Region

BODY COMPOSITION ANALYZERS MARKET: COMPANY EVALUATION MATRIX

In the body composition analyzers market matrix, GE Healthcare (Star) leads with a strong market share and product footprint, driven by its advanced equipment and technologies. Cosmed srl (Emerging Leader) is gaining visibility with its specialized body composition analyzer solutions, strengthening its position through innovation and niche clinical applications.

body-composition-analyzers-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 0.93 Billion
Market Forecast in 2026 (Value) USD 0.99 Billion
Market Forecast in 2031 (Value) USD 1.39 Billion
Growth Rate CAGR of 7.1% from 2026-2031
Years Considered 2024-2031
Base Year 2025
Forecast Period 2026-2031
Units Considered Value (USD Million/Billion), Volume (Units)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Product:
    • Bioimpedance Analyzers (Multi-frequency Bioimpedance Analyzers
    • Single-frequency Bioimpedance Analyzers
    • and Dual-frequency Bioimpedance Analyzers)
    • Dual-energy X-ray Absorptiometry Equipment
    • Skinfold Calipers
    • Air Displacement Plethysmography Equipment
    • and Hydrostatic Weighing Equipment
  • By Modality: Portable and Stationary/Benchtop
  • By Usage Type: Professional-Grade and Consumer-Grade
  • By Application: Segmental Body Measurement and Whole-body Measurement
  • By End User:
    • Hospitals & Clinics
    • Fitness Clubs & Wellness Centers
    • Academic & Research Centers
    • and Home Users
Regions Covered North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa

WHAT IS IN IT FOR YOU: BODY COMPOSITION ANALYZERS MARKET REPORT CONTENT GUIDE

body-composition-analyzers-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Product Analysis In-depth assessment of body composition analyzers by product (Bioimpedance Analyzers (Multi-frequency Bioimpedance Analyzers, Single-frequency Bioimpedance Analyzers, Dual-frequency Bioimpedance Analyzers), Dual-energy X-ray Absorptiometry Equipment, Skinfold Calipers, Air Displacement Plethysmography Equipment, and Hydrostatic Weighing Equipment), by modality (Portable Body Composition Analyzers, and Stationary/Benchtop Body Composition Analyzers), by usage type (Professional-Grade Body Composition Analyzers, and Consumer-Grade Body Composition Analyzers), by application (Segmental Body Measurement, and Whole-body Measurement), by distribution channel (e-commerce, and Offline/Retail Stores), by end users (Hospitals & Clinics, Fitness Clubs and Wellness Centers, Academic & Research Centers, and Home Users), along with evaluation of automation capabilities, patient convenience, and procedure efficiency.
  • AI-enabled analytics
  • Connected/cloud-based monitoring
  • Improved multi-frequency accuracy
  • App and wearable integration
Company Information Comprehensive profiles of leading global players such as GE HealthCare, OMRON Corporation, Hologic, Inc., InBody Co., Ltd., Tanita Corporation, and other Partners.
  • Strategic partnerships
  • Cloud-based reporting platforms
  • Regulatory developments
  • Launches of new products
  • Collaborations/mergers driving innovations and efficiencies
Geographic Analysis Region- and country-level demand mapping across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa; evaluation of regulatory frameworks, biologics adoption, pricing dynamics, and healthcare infrastructure.
  • Region-wise market outlook emphasizing growth opportunities offered by rising obesity and diabetes
  • Personalized health tracking
  • Emerging-market investments
  • Portable analyzer adoption

RECENT DEVELOPMENTS

  • July 2026 : GE HealthCare and Catholic Health entered a 10-year strategic Care Alliance valued at approximately USD 500 million. The agreement covers more than 1,300 pieces of technology across Catholic Health's hospitals and ambulatory sites, together with equipment, services, digital solutions, cloud solutions, and AI-enabled technologies.
  • July 2026 : OMRON joined Noetra to develop a Japan-originated AI foundation model, aiming to advance AI technology and applications.
  • July 2025 : DMS Group signed a strategic agreement with Innolux covering a potential investment by Innolux in DMS Group. The partnership is intended to strengthen DMS's position in medical imaging and combine DMS's medical-imaging expertise with Innolux's capabilities in display and X-ray detector technologies. The agreement provides for an initial investment and potential additional investment subject to conditions.

 

Table of Contents

checkmarkExclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
15
2
EXECUTIVE SUMMARY
 
 
 
 
3
PREMIUM INSIGHTS
 
 
 
 
4
MARKET OVERVIEW
Highlights the market structure, growth drivers, restraints, and near-term inflection points influencing performance.
 
 
 
 
 
4.1
INTRODUCTION
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
4.2.4
CHALLENGES
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
4.5
STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
 
 
 
5
INDUSTRY TRENDS
Outlines emerging trends, technology impact, and regulatory signals affecting growth trajectory and stakeholder decisions.
 
 
 
 
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
5.2
MACROECONOMIC OUTLOOK
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
5.2.2
GDP TRENDS AND FORECAST
 
 
 
 
5.2.3
TRENDS IN GLOBAL HEALTHCARE INDUSTRY
 
 
 
 
5.2.4
TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY
 
 
 
5.3
SUPPLY CHAIN ANALYSIS
 
 
 
 
 
5.4
VALUE CHAIN ANALYSIS
 
 
 
 
 
5.5
ECOSYSTEM ANALYSIS
 
 
 
 
 
5.6
PRICING ANALYSIS
 
 
 
 
 
 
5.6.1
AVERAGE SELLING PRICE TREND OF BODY COMPOSITION ANALYZERS OFFERED BY KEY PLAYERS, BY PRODUCT, 2023–2025
 
 
 
 
5.6.2
AVERAGE SELLING PRICE TREND OF BODY COMPOSITION ANALYZERS, BY REGION, 2023–2025
 
 
 
5.7
TRADE ANALYSIS
 
 
 
 
 
 
5.7.1
IMPORT SCENARIO (HS CODE 901819 AND 903180)
 
 
 
 
5.7.2
EXPORT SCENARIO (HS CODE 901819 AND 903180)
 
 
 
5.8
KEY CONFERENCES AND EVENTS, 2026–2027
 
 
 
 
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
5.10
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
5.11
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
 
 
 
 
5.12
IMPACT OF US TARIFFS – BODY COMPOSITION ANALYZERS MARKET
 
 
 
 
 
 
5.12.1
INTRODUCTION
 
 
 
 
5.12.2
KEY TARIFF RATES
 
 
 
 
5.12.3
PRICE IMPACT ANALYSIS
 
 
 
 
5.12.4
IMPACT ON COUNTRIES/REGIONS
 
 
 
 
 
5.12.4.1
NORTH AMERICA
 
 
 
 
5.12.4.2
ASIA PACIFIC
 
 
 
 
5.12.4.3
EUROPE
 
 
 
5.12.5
IMPACT ON END USERS
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
 
 
 
 
 
6.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
 
6.1.1
MULTI-FREQUENCY BIOELECTRICAL IMPEDANCE ANALYSIS (MF-BIA)
 
 
 
 
6.1.2
AI-ENABLED & CLOUD-CONNECTED BODY COMPOSITION ANALYSIS
 
 
 
6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
6.2.1
DUAL-ENERGY X-RAY ABSORPTIOMETRY (DEXA/DXA)
 
 
 
 
6.2.2
AIR DISPLACEMENT PLETHYSMOGRAPHY (ADP)
 
 
 
6.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
6.3.1
3D OPTICAL BODY SCANNING SYSTEMS
 
 
 
 
6.3.2
SMARTPHONE-BASED BODY COMPOSITION ASSESSMENT & DIGITAL HEALTH PLATFORMS
 
 
 
6.4
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
6.5
PATENT ANALYSIS
 
 
 
 
 
6.6
FUTURE APPLICATIONS
 
 
 
 
6.7
IMPACT OF AI/GEN AI ON BODY COMPOSITION ANALYZERS MARKET
 
 
 
 
 
 
6.7.1
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
6.7.2
BEST PRACTICES FOLLOWED BY MANUFACTURERS IN BODY COMPOSITION ANALYZERS MARKET
 
 
 
 
6.7.3
CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION IN BODY COMPOSITION ANALYZERS MARKET
 
 
 
 
6.7.4
INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
6.7.5
CLIENTS’ READINESS TO ADOPT AI/GEN AI-INTEGRATED BODY COMPOSITION ANALYZERS
 
 
7
REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
 
 
 
 
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
7.2
REGIONAL REIMBURSEMENT SCENARIO
 
 
 
 
 
7.2.1
REIMBURSEMENT SCENARIO FOR BODY COMPOSITION ANALYZERS MARKET
 
 
 
7.3
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
 
 
 
 
7.4
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
 
 
 
8
CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
 
 
 
 
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
8.2
KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
 
 
 
 
 
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
8.2.2
BUYING CRITERIA
 
 
 
8.3
ADOPTION BARRIERS AND INTERNAL CHALLENGES
 
 
 
 
8.4
UNMET NEEDS OF VARIOUS END USERS
 
 
 
 
8.5
MARKET PROFITABILITY
 
 
 
9
BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN UNITS)
 
 
 
 
 
9.1
INTRODUCTION
 
 
 
 
9.2
GLOBAL VOLUME ANALYSIS OF BODY COMPOSITION ANALYZER PRODUCTS, 2024–2031 (THOUSAND UNITS)
 
 
 
 
9.3
BIOIMPEDANCE ANALYZERS
 
 
 
 
 
9.3.1
MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS
 
 
 
 
9.3.2
SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS
 
 
 
 
9.3.3
DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS
 
 
 
9.4
DUAL-ENERGY X-RAY ABSORPTIOMETRY EQUIPMENT
 
 
 
 
9.5
SKINFOLD CALIPERS
 
 
 
 
9.6
AIR DISPLACEMENT PLETHYSMOGRAPHY EQUIPMENT
 
 
 
 
9.7
HYDROSTATIC WEIGHING EQUIPMENT
 
 
 
10
BODY COMPOSITION ANALYZERS MARKET, BY MODALITY (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN UNITS)
 
 
 
 
 
10.1
INTRODUCTION
 
 
 
 
10.2
PORTABLE
 
 
 
 
10.3
STATIONARY/BENCHTOP
 
 
 
11
BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN UNITS)
 
 
 
 
 
11.1
INTRODUCTION
 
 
 
 
11.2
PROFESSIONAL-GRADE
 
 
 
 
11.3
CONSUMER-GRADE
 
 
 
12
BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
 
 
 
 
 
12.1
INTRODUCTION
 
 
 
 
12.2
SEGMENTAL BODY MEASUREMENT
 
 
 
 
12.3
WHOLE-BODY MEASUREMENT
 
 
 
14
BODY COMPOSITION ANALYZERS MARKET, BY END USER (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
 
 
 
 
 
14.1
INTRODUCTION
 
 
 
 
14.2
FITNESS CLUBS & WELLNESS CENTERS
 
 
 
 
14.3
HOSPITALS & CLINICS
 
 
 
 
14.4
ACADEMIC & RESEARCH CENTERS
 
 
 
 
14.5
HOME USERS
 
 
 
15
BODY COMPOSITION ANALYZERS MARKET, BY REGION (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN UNITS)
 
 
 
 
 
15.1
INTRODUCTION
 
 
 
 
15.2
NORTH AMERICA
 
 
 
 
 
15.2.1
NORTH AMERICA VOLUME ANALYSIS – 2024–2031 (UNITS)
 
 
 
 
15.2.2
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
 
 
 
 
15.2.3
US
 
 
 
 
15.2.4
CANADA
 
 
 
15.3
EUROPE
 
 
 
 
 
15.3.1
EUROPE VOLUME ANALYSIS – 2024–2031 (UNITS)
 
 
 
 
15.3.2
MACROECONOMIC OUTLOOK FOR EUROPE
 
 
 
 
15.3.3
GERMANY
 
 
 
 
15.3.4
UK
 
 
 
 
15.3.5
FRANCE
 
 
 
 
15.3.6
ITALY
 
 
 
 
15.3.7
SPAIN
 
 
 
 
15.3.9
REST OF EUROPE
 
 
 
15.4
ASIA PACIFIC
 
 
 
 
 
15.4.1
ASIA PACIFIC VOLUME ANALYSIS – 2024–2031 (UNITS)
 
 
 
 
15.4.2
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
 
 
 
 
15.4.3
JAPAN
 
 
 
 
15.4.4
CHINA
 
 
 
 
15.4.5
INDIA
 
 
 
 
15.4.6
AUSTRALIA
 
 
 
 
15.4.7
SOUTH KOREA
 
 
 
 
15.4.8
REST OF ASIA PACIFIC
 
 
 
15.5
LATIN AMERICA
 
 
 
 
 
15.5.1
LATIN AMERICA VOLUME ANALYSIS – 2024–2031 (UNITS)
 
 
 
 
15.5.2
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
 
 
 
 
15.5.3
BRAZIL
 
 
 
 
15.5.4
MEXICO
 
 
 
 
15.5.5
REST OF LATIN AMERICA
 
 
 
15.6
MIDDLE EAST & AFRICA
 
 
 
 
 
15.6.1
MIDDLE EAST & AFRICA VOLUME ANALYSIS – 2024–2031 (UNITS)
 
 
 
 
15.6.2
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
 
 
 
 
15.6.3
GCC COUNTRIES
 
 
 
 
 
15.6.3.1
SAUDI ARABIA
 
 
 
 
15.6.3.2
UAE
 
 
 
 
15.6.3.3
OTHER GCC COUNTRIES
 
 
 
15.6.4
REST OF MIDDLE EAST & AFRICA
 
 
16
COMPETITIVE LANDSCAPE
 
 
 
 
 
16.1
OVERVIEW
 
 
 
 
16.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2023–2026
 
 
 
 
16.3
REVENUE ANALYSIS, 2021–2025
 
 
 
 
 
16.4
MARKET SHARE ANALYSIS,
 
 
 
 
 
 
16.4.1
US MARKET SHARE ANALYSIS,
 
 
 
 
16.4.2
EUROPE MARKET SHARE ANALYSIS,
 
 
 
16.6
BRAND/PRODUCT COMPARISON
 
 
 
 
 
16.7
COMPANY EVALUATION MATRIX: KEY PLAYERS,
 
 
 
 
 
 
16.7.1
STARS
 
 
 
 
16.7.2
EMERGING LEADERS
 
 
 
 
16.7.3
PERVASIVE PLAYERS
 
 
 
 
16.7.4
PARTICIPANTS
 
 
 
 
16.7.5
COMPANY FOOTPRINT: KEY PLAYERS,
 
 
 
 
 
16.7.5.1
COMPANY FOOTPRINT
 
 
 
 
16.7.5.2
REGION FOOTPRINT
 
 
 
 
16.7.5.3
PRODUCT FOOTPRINT
 
 
 
 
16.7.5.4
MODALITY FOOTPRINT
 
 
 
 
16.7.5.5
USAGE TYPE FOOTPRINT
 
 
16.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
 
 
 
 
 
 
16.8.1
PROGRESSIVE COMPANIES
 
 
 
 
16.8.2
RESPONSIVE COMPANIES
 
 
 
 
16.8.3
DYNAMIC COMPANIES
 
 
 
 
16.8.4
STARTING BLOCKS
 
 
 
 
16.8.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
 
 
 
 
 
16.8.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
16.8.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
 
 
16.9
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
16.10
COMPETITIVE SCENARIO
 
 
 
 
 
16.10.1
PRODUCT LAUNCHES
 
 
 
 
16.10.2
DEALS
 
 
 
 
16.10.3
EXPANSIONS
 
 
 
 
16.10.4
OTHER DEVELOPMENTS
 
 
17
COMPANY PROFILES
 
 
 
 
 
17.1
KEY PLAYERS
 
 
 
 
 
17.1.1
OMRON CORPORATION
 
 
 
 
17.1.2
HOLOGIC, INC.
 
 
 
 
17.1.3
GE HEALTHCARE
 
 
 
 
17.1.4
INBODY CO., LTD.
 
 
 
 
17.1.5
TANITA CORPORATION
 
 
 
 
17.1.6
SECA
 
 
 
 
17.1.7
WITHINGS
 
 
 
 
17.1.8
SELVAS HEALTHCARE, INC.
 
 
 
 
17.1.9
COSMED SRL
 
 
 
 
17.1.10
RJL SYSTEMS
 
 
 
 
17.1.11
IMPEDIMED LIMITED
 
 
 
 
17.1.12
CHARDER ELECTRONIC CO., LTD.
 
 
 
 
17.1.13
BODYSTAT LIMITED
 
 
 
 
17.1.14
DMS IMAGING
 
 
 
 
17.1.15
XIAOMI INC
 
 
 
 
17.1.16
A&D COMPANY, LIMITED
 
 
 
17.2
OTHER PLAYERS
 
 
 
 
 
17.2.1
MALTRON INTERNATIONAL LTD.
 
 
 
 
17.2.2
AKERN S.R.L.
 
 
 
 
17.2.3
BIOTEKNA
 
 
 
 
17.2.4
BIODYNAMICS CORPORATION
 
 
 
 
17.2.5
MICROLIFE CORPORATION
 
 
 
 
17.2.6
NUMED S.A.R.L.
 
 
 
 
17.2.7
TONGYONG TIZHI HEALTH TECHNOLOGY CO., LTD.
 
 
 
 
17.2.8
FOOK TIN TECHNOLOGIES LTD.
 
 
 
 
17.2.9
OSTEOSYS CORP.
 
 
 
 
17.2.10
EXERTECH
 
 
 
 
17.2.11
SHANGHAI GOLDENWELL MEDICAL TECHNOLOGY CO., LTD
 
 
18
RESEARCH METHODOLOGY
 
 
 
 
 
18.1
RESEARCH DATA
 
 
 
 
 
18.1.1
SECONDARY DATA
 
 
 
 
 
18.1.1.1
LIST OF KEY SECONDARY SOURCES
 
 
 
 
18.1.1.2
KEY DATA FROM SECONDARY SOURCES
 
 
 
18.1.2
PRIMARY DATA
 
 
 
 
 
18.1.2.1
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
18.1.2.2
LIST OF PRIMARY INTERVIEW PARTICIPANTS
 
 
 
 
18.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
18.1.2.4
KEY INDUSTRY INSIGHTS
 
 
18.2
MARKET SIZE ESTIMATION
 
 
 
 
 
18.2.1
APPROACH 1: COMPANY REVENUE ANALYSIS APPROACH
 
 
 
 
18.2.2
APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
 
 
 
 
18.2.3
APPROACH 3: BOTTOM-UP APPROACH
 
 
 
 
18.2.4
APPROACH 4: TOP-DOWN APPROACH
 
 
 
 
18.2.5
APPROACH 5: PRIMARY INTERVIEWS
 
 
 
 
18.2.6
APPROACH 6: DEMAND-SIDE APPROACH
 
 
 
 
18.2.7
APPROACH 7: VOLUME DATA ANALYSIS
 
 
 
18.3
MARKET FORECAST APPROACH
 
 
 
 
 
18.3.1
SUPPLY SIDE
 
 
 
 
18.3.2
DEMAND SIDE
 
 
 
18.4
DATA TRIANGULATION
 
 
 
 
18.5
FACTOR ANALYSIS
 
 
 
 
18.6
RESEARCH ASSUMPTIONS
 
 
 
 
18.7
RESEARCH LIMITATIONS
 
 
 
 
18.8
RISK ANALYSIS
 
 
 
19
APPENDIX
 
 
 
 
 
19.1
DISCUSSION GUIDE
 
 
 
 
19.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
19.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
19.3.1
PRODUCT ANALYSIS
 
 
 
 
19.3.2
COMPANY INFORMATION
 
 
 
 
19.3.3
GEOGRAPHIC ANALYSIS
 
 
 
 
19.3.4
REGIONAL/COUNTRY LEVEL MARKET SHARE ANALYSIS
 
 
 
 
19.3.5
COUNTRY LEVEL VOLUME ANALYSIS
 
 
 
 
19.3.6
BY PRODUCT MARKET SHARE ANALYSIS (TOP FIVE PLAYERS)
 
 
 
 
19.3.7
ANY CONSULTS/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
 
 
 
19.4
RELATED REPORTS
 
 
 
 
19.5
AUTHOR DETAILS
 
 
 

 

Methodology

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the body composition analyzers market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends, to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the body composition analyzers market. The primary sources from the demand side include medical OEMs, medical device ISOs, and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights into key industry trends & key market dynamics.

Breakdown of Primary Interviews

A breakdown of the primary respondents for the body composition analyzers market (supply side) is provided below:

Body Composition Analyzers Market 
 Size, and Share

Note: Others include sales, marketing, and product managers.
Companies are classified into tiers based on their total revenue.
As of 2025, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = <USD 50 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

In this report, the global body composition analyzers market size was arrived at by using the revenue share analysis of leading players. For this purpose, key players were identified, and their revenues from the body composition analyzer business were determined through various insights gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and key marketing executives.

To calculate the global market value, segmental revenues were calculated based on the revenue mapping of major solution/service providers. This process involves the following steps:

  • Generating a list of major global players operating in the body composition analyzers market
  • Mapping annual revenues generated by major global players from the body composition analyzers segment (or nearest reported business unit/service category)
  • Revenue mapping of key players to cover a major share of the global market as of 2025
  • Extrapolating the global value of the market

Top-Down and Bottom-Up Approach

Body Composition Analyzers Market Top Down and Bottom Up Approach

Data Triangulation

After arriving at the overall market size from the market size estimation process explained above, the global body composition analyzers market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. Additionally, the market was validated using both top-down and bottom-up approaches.

Market Definition

Body composition analyzers consist of devices and systems that quantitatively measure a person’s body composition, which includes different parameters such as body fat mass, percentage of body fat, body muscle mass, lean mass, total body water amount, bone mass, and visceral fat. To estimate or assess body composition, analyzers employ various technologies such as bioelectrical impedance analysis (BIA), dual-energy X-ray absorptiometry (DEXA/DXA), skinfold measurement, air displacement plethysmography, and hydrostatic weighing.

Key Stakeholders

  • Body composition analyzer manufacturing companies
  • Original equipment manufacturing companies
  • Body composition analyzer Suppliers and distributors
  • Healthcare service providers
  • Health insurance payers
  • Government bodies/municipal corporations
  • Regulatory bodies
  • Medical research institutes
  • Business research and consulting service providers
  • Venture capitalists
  • Market research and consulting firms

Report Objectives

  • To describe and forecast the global body composition analyzers market, by product, usage type, modality, application, end user, and region, in terms of value
  • To forecast the global body composition analyzers market, by product, in terms of volume
  • To forecast the size of the market segments concerning five main regions, namely North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, in terms of value
  • To provide detailed information regarding the major factors influencing the market growth
    (such as drivers, restraints, opportunities, and challenges) along with the current trends
  • To strategically analyze micromarkets concerning individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the global market for stakeholders and provide details of the competitive landscape for market leaders
  • To profile the key players and analyze their market shares and core competencies
  • To track and analyze competitive developments, such as product launches, partnerships, agreements, collaborations, expansions, strategic alliances, and acquisitions, in the global market
  • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

Available customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global body composition analyzers market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top twelve companies

Company Information

  • Detailed analysis and profiling of additional market players (up to 10)

Geographic Analysis

  • Further breakdown of the Rest of Europe’s body composition analyzers market into Russia, Finland, Switzerland, Turkey, the Czech Republic, the Netherlands, Norway, Poland, Portugal, Romania, Estonia, Austria, Belgium
  • Further breakdown of the Rest of Asia Pacific’s body composition analyzers market into Taiwan, New Zealand, and Sri Lanka
  • Further breakdown of the Rest of Latin America’s body composition analyzers market into Uruguay, Costa Rica, Bolivia, Venezuela, and Paraguay

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Body Composition Analyzers Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Body Composition Analyzers Market

DMCA.com Protection Status
popup img